Fig. 5From: Dosimetric impact of Ac-227 in accelerator-produced Ac-225 for alpha-emitter radiopharmaceutical therapy of patients with hematological malignancies: a pharmacokinetic modeling analysisResults of A Ab PK model simulations for 225Ac-bound Ab. B PK for free 227Th C PK for free 223RaBack to article page